Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata may be linked to heart issues.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Different PCOS types respond uniquely to infertility treatments, with some having lower pregnancy rates and higher risks of complications.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Imaging helps detect adrenal gland issues and monitor treatment in congenital adrenal hyperplasia, and can identify tumors affecting fertility.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

A genetic mutation in the DCAF17 gene caused Woodhouse-Sakati syndrome in a Chinese patient from a related family.

Premature aging increases the risk of immune problems and autoimmune diseases.

Shock can be an early sign of Autoimmune Polyendocrine Syndrome Type II.

Some alternative treatments for hair loss might work, but more research is needed.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The document concludes that early diagnosis of Balint's syndrome is crucial for effective treatment and that understanding drug interactions, like between ritonavir and statins, is important for patient care.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

Young women with PCOS without additional risk factors may have normal heart function.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.